NCT00978185

Brief Summary

RATIONALE: Acupressure wristbands may prevent or reduce nausea caused by chemotherapy. It is not yet known whether acupressure wristbands are more effective than standard care in controlling acute and delayed nausea. PURPOSE: This randomized phase III trial is studying acupressure wristbands to see how well they work compared with standard care in controlling nausea caused by chemotherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
699

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Nov 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 16, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
Last Updated

August 26, 2013

Status Verified

September 1, 2009

Enrollment Period

1.9 years

First QC Date

September 15, 2009

Last Update Submit

August 23, 2013

Conditions

Keywords

nausea and vomitinganxiety disorderunspecified adult solid tumor, protocol specific

Outcome Measures

Primary Outcomes (1)

  • Incidence and severity of nausea as assessed by the Rhodes Index of Nausea & Vomiting before and after chemotherapy

Secondary Outcomes (6)

  • Incidence and extent of acute and delayed nausea and vomiting by the MASCC Antiemesis Tool at day 10 of each course

  • Quality of life as assessed by FACT-G at baseline and at day 10 of each course

  • Anxiety as assessed by the Hospital Anxiety & Depression Scale at baseline

  • Expectation for nausea and vomiting as assessed by the Patient Expectations of Nausea/Vomiting after each chemotherapy course

  • Measure of blindness (to intervention vs sham) assessed after chemotherapy

  • +1 more secondary outcomes

Interventions

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
DISEASE CHARACTERISTICS: * Diagnosis of any cancer * Scheduled to receive their first chemotherapy course * Scheduled to receive highly, moderately, or low-emetogenic chemotherapy * Scheduled to receive a chemotherapy regimen given as a single administration at the beginning of the course repeated in 3-week courses * Currently receiving adjuvant chemotherapy as outpatient * Acupressure wristband-naïve (in terms of never having tried such a wristband; may have seen or heard about such wristbands) PATIENT CHARACTERISTICS: * Able to perform self care (i.e., no inability to use wristbands appropriately or mental incapacity preventing continuous and optimal use of wristbands) as judged by the investigators * No liver disease * No metabolic risk factors for nausea (i.e., electrolyte imbalances causing nausea/vomiting) * No mechanical risk factors for nausea (i.e., intestinal obstruction) * No nausea and/or vomiting due to use of opioids * No lymphedematous arms * No chronic alcohol use PRIOR CONCURRENT THERAPY: * No concurrent radiotherapy * No concurrent chemotherapy regimens as inpatients

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

University of Manchester

Manchester, England, M13 9PL, United Kingdom

Location

MeSH Terms

Conditions

Anxiety DisordersNauseaVomiting

Interventions

Acupressure

Condition Hierarchy (Ancestors)

Mental DisordersSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Alex Molassiotis, MD

    University of Manchester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Purpose
SUPPORTIVE CARE
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 15, 2009

First Posted

September 16, 2009

Study Start

November 1, 2008

Primary Completion

October 1, 2010

Study Completion

October 1, 2010

Last Updated

August 26, 2013

Record last verified: 2009-09

Locations